Lukas E. Dow
Impact in
- Aging top 2%
- Molecular Biology top 1%
- CRISPR and Genetic Engineering
- Wnt/β-catenin signaling in development and cancer
- RNA Interference and Gene Delivery
- Cancer-related gene regulation
Papers in
-
- CRISPR and Genetic Engineering 27
- Wnt/β-catenin signaling in development and cancer 11
- RNA Interference and Gene Delivery 9
- Advanced biosensing and bioanalysis techniques 7
- Genetics 18
- Virus-based gene therapy research 7
- Co-authors
- Scott W. Lowe (29 shared papers)Patrick O. Humbert (8 shared papers)Emma M. Schatoff (13 shared papers)Kevin P. O’Rourke (7 shared papers)Darjus F. Tschaharganeh (6 shared papers)Alyna Katti (7 shared papers)Benjamin I. Leach (4 shared papers)Sarah M. Russell (4 shared papers)
- Journals
- Cancer Research (5 papers)Nature Biotechnology (5 papers)Cancer Discovery (5 papers)Oncogene (4 papers)Cell Reports (4 papers)
- Partner nations
- United StatesAustraliaGermany
In The Last Decade
Lukas E. Dow
72 papers receiving 6.2k citations
Lukas E. Dow's Hit Papers
Peers
Comparison fields: 5 of 128
- Aging 117
- Molecular Biology 4.0k
- Cancer Research 767
- Business and International Management 116
- Cell Biology 807
Countries citing papers authored by Lukas E. Dow
This map shows the geographic impact of Lukas E. Dow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lukas E. Dow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lukas E. Dow more than expected).
Fields of papers citing papers by Lukas E. Dow
This network shows the impact of papers produced by Lukas E. Dow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lukas E. Dow. The network helps show where Lukas E. Dow may publish in the future.
Co-authors
The 25 scholars most cited alongside Lukas E. Dow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH Hit paper breakdown → | 2015 | 741 |
| 2 | Apc Restoration Promotes Cellular Differentiation and Reestablishes Crypt Homeostasis in Colorectal Cancer Hit paper breakdown → | 2015 | 412 |
| 3 | 2015 | 404 | |
| 4 | CRISPR in cancer biology and therapy Hit paper breakdown → | 2022 | 310 |
| 5 | 2018 | 262 | |
| 6 | 2011 | 244 | |
| 7 | 2017 | 236 | |
| 8 | 2019 | 235 | |
| 9 | 2005 | 220 | |
| 10 | Dietary fructose improves intestinal cell survival and nutrient absorption Hit paper breakdown → | 2021 | 208 |
| 11 | 2010 | 197 | |
| 12 | 2017 | 180 | |
| 13 | 2006 | 155 | |
| 14 | 2011 | 150 | |
| 15 | 2019 | 148 | |
| 16 | 2014 | 145 | |
| 17 | 2008 | 141 | |
| 18 | 1998 | 135 | |
| 19 | 2006 | 130 | |
| 20 | 2012 | 123 |
About Lukas E. Dow
Lukas E. Dow is a scholar working on Molecular Biology, Genetics, Oncology, Cancer Research and Cell Biology, having authored 77 papers that have together received 6.3k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (27 papers), Wnt/β-catenin signaling in development and cancer (11 papers), Cancer Cells and Metastasis (10 papers), RNA Interference and Gene Delivery (9 papers), Hippo pathway signaling and YAP/TAZ (7 papers), Advanced biosensing and bioanalysis techniques (7 papers), Virus-based gene therapy research (7 papers) and Cancer Genomics and Diagnostics (6 papers). The work is most often cited by research in Aging (117 citations), Molecular Biology (4.0k citations), Cancer Research (767 citations), Business and International Management (116 citations) and Cell Biology (807 citations). Lukas E. Dow has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include Scott W. Lowe, Patrick O. Humbert, Emma M. Schatoff, Kevin P. O’Rourke, Darjus F. Tschaharganeh, Alyna Katti, Benjamin I. Leach, Sarah M. Russell, Ashlesha Muley and Janelle Simon. Their work appears in journals such as Cancer Research, Nature Biotechnology, Cancer Discovery, Oncogene and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.